个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
刘晓艳,博士,研究员,副教授,硕士研究生导师。2013年博士毕业于北京协和医学院阜外心血管病医院。长期从事肺动脉高压及相关疾病基础及临床研究,前期创建了一种新型的体-肺分流性肺动脉高压大鼠模型,并进一步深入探讨了体-肺分流性肺动脉高压血管重构的机制,发现了多种参与其中的重要分子。近年来围绕肠道微生态与肺动脉高压及相关疾病的关系开展了系列创新性研究,发现肠道真菌在肺动脉高压相关疾病的发病机制中具有重要作用,是新的治疗靶点。
先后主持国家自然科学基金青年项目、北京市自然科学基金面上项目、国家自然科学基金面上项目等科研项目10余项,作为科研骨干参与国家重点基础研究发展计划、国家重点研发计划、国家自然科学基金青年项目等,可执行经费合计450万元。以第一/通讯作者在EBioMedicine, MATRIX BIOL, FASEB J, ACTA PHYSIOL等领域内权威杂志发表SCI论文20余篇。获批国家发明专利3项,其中科技成果转化1项。已指导两名研究生分别发表IF>10研究论文一篇,一名研究生获百洋博士生奖学金。入选北京市医管中心“青苗”人才,北京朝阳医院“朝阳新星”人才。担任iMeta杂志青年编委,Frontiers in Microbiology杂志编委。中国病理生理学会委员,中国中药协会心血管药物研究专业委员会委员,中国药理学会表观遗传药理学专业委员会委员。

1. 国家自然科学基金面上项目,82570072,肠道菌B.obeum代谢产物D-阿洛糖抑制肺动脉内皮铁死亡改善特发性肺动脉高压的作用机制,2026/01-2029/12,49万元,在研,主持。
2. 国家自然科学基金面上项目,82170302,长链非编码RNA/SNHG29在体-肺分流性肺动脉高压肺血管重构中的作用与机制,2022/01-2025/12,55万元,在研,主持;
3. 北京市呼吸疾病研究所“预算编制项目”子课题,Ysbz2025007,肠道微生态在肺动脉高压中的作用与机制研究,2025/01-2027/12,414万元,在研,主持;
1. 重要学术论文
(1) Chen Y#, Chen Z#, Liang L#, Li J#, Meng L, Yuan W, Xie B, Zhang X, Feng L, Jia Y, Fu Z, Su P, Tong Z*,Zhong J*, Liu X*. Multi-kingdom GutMicrobiota Dysbiosis is Associated with the Development of Pulmonary ArterialHypertension. EBioMedicine. 2025; 115:105686.
(2) An K#, Jia Y#, Xie B#, Gao J#, Chen Y, Yuan W,Zhong J*, Su P*, Liu X*. Alterations in the gut mycobiome with coronary artery disease severity. EBioMedicine,2024, 103, 105137
(3) Fu Z#, Jia Y#, Zhao J, Guo Y, Xie B, An K, Yuan W, Chen Y, Zhong J, TongZ, Liu X* and Su P*. Perioperative Multi-Kingdom Gut Microbiota Altersin Coronary Artery Bypass Grafting.BIOMEDICINES. 2025; 13(2).
(4) Wan L#, Wang H#, Liang Y#, Zhang X#, Yao X, Zhu G, Cai J, Liu G, Liu X,Niu Q, Li S, Zhang B, Gao J, Wang J, Shi X, Hu L, Liu X*, Zou Z*, Yang G*. 2024. Effect of oral faecal microbiota transplantationintervention for children with autism spectrum disorder: A randomised, double‐blind, placebo‐controlled trial.Clinical and Translational Medicine, 2024, 14(9) e70006.
(5) Liu X#, Zhang Y#, Yuan W, Han R, Zhong J, Yang X*,Zheng M*, Xie B*. Exosomal CircRNAs in Circulation Serve as Diagnostic Biomarkers for AcuteMyocardial Infarction. Front Biosci (Landmark Ed). 2024;29(4):149.
(6) Chen Y#, Meng L#, Yuan W, Gao Z, Zhang X, Xie B, Song J, Li J, Zhong J*and Liu X*. Gut Fungal Microbiota Alterations in Pulmonary Arterial HypertensiveRats. Biomedicines. 2024; 12(2):298.
(7) Liu X#, Zheng M#, Han R#, Yu Z, Yuan W, Xie B, Zhang Y,Zhong J, Wang L, Wang L* and Liu X*. Circulating Exosomal CircRNAs asDiagnostic Biomarkers for Chronic Coronary Syndrome. METABOLITES. 2023;13(10):1066.
(8) Zheng M#, Han R#, Yuan W#, Chi H, Zhang Y, Sun K, Zhong J*, Liu X* and Yang X*.Circulating exosomal lncRNAs in patients with chronic coronary syndromes. ARCHMED SCI. 2023; 19(1):46-56.
(9) Chen Y, Yuan W, Meng L, ZhongJ*, Liu X*, The Role and Mechanism of Gut Microbiota inPulmonary Arterial Hypertension. Nutrients. 2022 Oct 13;14(20):4278.
(10) Liu X#, Chen Z#, Li S#, Jin L, Cui X, Cui C, Deng Y, Gao Q, Fan L, Niu Y, WangW, Cui C, Zhong J, Cui Q*, Geng B* and Cai J*. Pre-miRNA Hsa-Let-7a-2: a NovelIntracellular Partner of Angiotensin II Type 2 Receptor Negatively Regulatingits Signals. INT J BIOL SCI. 2022; 18(8):3237-3250.
(11) Meng L#, Yuan W#, Chi H, Han R, Zhang Y, Pan X, Meng J, Liu Y, Song J,Zhong J*, Liu X*, Genetic deletion ofCMG2 exacerbates systemic-to-pulmonary shunt-induced pulmonary arterialhypertension. FASEB J. 2021; 35(4):e21421.
(12) Meng L, Teng X, Liu Y, Yang C, Wang S, Yuan W, Meng J, Chi H, Duan L*& Liu X*. Vital Roles ofGremlin-1 in Pulmonary Arterial Hypertension Induced by Systemic-to-PulmonaryShunts. J Am Heart Assoc 2020; Aug 4;9(15):e016586.
(13) MengL#, Liu X#, Teng X, Yuan W,Meng J, Li J, Zheng Z, Wei Y, Hu S*. DAN plays important compensatory roles insystemic-to-pulmonary shunt associated pulmonary arterial hypertension. ActaPhysiol (Oxf), 2019 Feb 4:e13263.
(14) MengL#, Liu X#, Teng X, Gu H, Yuan W, Meng J, Li J, Zheng Z, Wei Yand Hu S: Osteopontin plays important roles in pulmonary arterial hypertensioninduced by systemic-to-pulmonary shunt. The FASEB Journal,2019 33(6):7236-7251.
(15) Zheng M#, Liu X#,Han R#, Yuan W, Sun K, Zhong J*, Yang X*. Circulating Exosomal Long NoncodingRNAs in Patients with Acute Myocardial Infarction. J Cell Mol Med. 2020Aug;24(16):9388-9396.
(16) Liu X, Yuan W, Yang L, Li J, Cai J. miRNA Profiling of Exosomes from Spontaneous Hypertensive Rats UsingNext-Generation Sequencing. Journal of Cardiovascular TranslationalResearch. 2019 Feb;12(1):75-83.
(17) LiuX, Yuan W, Li J, Yang L, Cai J. ANTXR2Knock-Out Does Not Result in the Development of Hypertension in Rats. Am JHypertens. 2017; 30(2): 182-187.
(18) Liu X#, MengL#, Li J, Meng J, Teng X, Gu H, Hu S* & Wei Y*. Secretoryclusterin is upregulated in rats with pulmonary arterial hypertension inducedby systemic-to-pulmonary shunts and exerts important roles in pulmonary arterysmooth muscle cells. Acta Physiologica 2015;213(2):505-518.
(19) Liu X#,Meng L#, Shi Q, Liu S, Cui C, Hu S*, Wei Y*. Dermatopontin promotes adhesion,spreading and migration of cardiac fibroblasts in vitro. Matrix Biology 2013;32(1): 23-31.
(20) Meng L#, Liu X#, Zheng Z, Li J, Meng J, Wei Y*, HuS*. Original rat model of high kinetic unilateral pulmonary hypertensionsurgically induced by combined surgery. The Journal of Thoracic andCardiovascular Surgery 2013; 146(5): 1220-26.
(21) Liu X#, Hu C#, Bao M#, Li J#, LiuX#, Tan X, Zhou Y, Chen Y, Wu S, Chen S, Zhang R, Jiang F, Jia W, WangX*, Yang X*, Cai J*. Genome Wide Association Study Identifies L3MBTL4as a Novel Susceptibility Gene for Hypertension. ScientificReports 6(1). 2016, 6:30811.
2. 重要奖项
(1) 呼吸危重症&肺动脉高压前沿一带一路青年呼吸论坛优秀青年学者奖
(2) 首都医科大学2023年度科技奖励自然科学奖 二等奖

文件上传中...